Chemistry42

Overview

Chemistry42 brings molecular generation, predictive profiling, and physics-based analysis into a small-molecule drug discovery workflow. The official product page positions it for hit identification, hit-to-lead development, and lead optimization. Users can start ligand-based or structure-based design, generate candidate molecules against selected criteria, and prioritize those candidates with complementary analysis tools rather than treating generation as an isolated task.

Documented inputs include a target protein and/or ligand, a pharmacophore hypothesis, an anchor hypothesis for preserving 3D fragments, and a desired compound and ADMET profile. Outputs described on the page include generated molecular structures, predicted synthetic routes, ADMET and selectivity predictions, and relative binding free-energy estimates. Result inspection includes filtering, viewing generated molecules in a binding site, and visualizing building blocks. MolSpace provides Generative Topographic Mapping to explore generation results and compare them with public data.

The platform also supports training predictive models on user datasets, including in vitro activity or simulation data, and incorporating external QSAR models, molecular dynamics simulators, and in-house databases. MDFlow covers biomolecular simulation from system preparation and sampling through reporting and metrics. Retrosynthesis uses expert-annotated reaction templates and a searchable collection of commercially available building blocks.

These capabilities are vendor-described, not independently evaluated here. The supplied page does not establish predictive accuracy for a particular project, accepted file formats, or integration requirements. Its predictions and proposed routes should be evaluated against project-specific experimental evidence; access and service conditions require separate inspection.

Key Features

• Generative Chemistry supports de novo design, hit optimization, scaffold hopping, and R-group exploration within ligand-based or structure-based workflows.
• Retrosynthesis predicts routes for uploaded or generated structures using expert-annotated reaction templates, with building blocks searchable by CAS registry numbers and support for chemo-, regio-, and stereo-selectivity.
• ADMET & Off-target provides predictive profiling and optimization, either independently or within generative experiments; Golden Cubes targets off-target kinome selectivity using 2D and 3D structures.
• Alchemistry estimates relative protein–ligand binding free energies for compound prioritization and can incorporate experimental data to determine absolute binding free energy.
• Model Training uses custom datasets, including in vitro activity or simulation data, to build predictive models for generation guidance and dataset annotation.
• MDFlow provides biomolecular and complex simulation workflows covering system build, sampling, reporting, and metrics.

Use Cases

• Suggested evaluation: explore scaffold-hopping or R-group alternatives around an existing ligand while specifying a pharmacophore or a 3D fragment-preservation hypothesis.
• Suggested evaluation: prioritize generated lead candidates by comparing ADMET predictions, selectivity profiles, and relative binding free-energy estimates with available experimental measurements.
• Suggested evaluation: assess synthetic accessibility of uploaded or generated molecules by reviewing proposed routes and their commercially available building blocks.
• Suggested evaluation: train a project-specific predictive model on activity or simulation data and assess its suitability for guiding subsequent molecular generation.

How to Use

1. Review the Chemistry42 product page to identify the relevant discovery stage and modules. Inspect the linked end-user terms before pursuing access.
2. Use the official access request or login link. Confirm input formats, account permissions, and integration requirements with the provider; the excerpt does not specify them.
3. Plan a Generative Chemistry experiment around a protein and/or ligand. Define the compound profile, desired ADMET properties, and any pharmacophore or fragment-preservation hypotheses.
4. Review and filter generated candidates. Consider ADMET profiling and Alchemistry for prioritization, treating their outputs as predictions to evaluate rather than experimental findings.
5. Inspect retrosynthesis proposals and building blocks for shortlisted structures. As an intended evaluation step, compare proposed chemistry and predicted properties with medicinal-chemistry judgment and available laboratory evidence before advancing candidates.